Billy Wu

630 total citations
18 papers, 431 citations indexed

About

Billy Wu is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Billy Wu has authored 18 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in General Health Professions. Recurrent topics in Billy Wu's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Heart Failure Treatment and Management (3 papers) and Health Promotion and Cardiovascular Prevention (3 papers). Billy Wu is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Heart Failure Treatment and Management (3 papers) and Health Promotion and Cardiovascular Prevention (3 papers). Billy Wu collaborates with scholars based in New Zealand, United Kingdom and Poland. Billy Wu's co-authors include Rod Jackson, Andrew Kerr, Corina Grey, Katrina Poppe, Matire Harwood, Sue Wells, Daniel Exeter, Suneela Mehta, Romana Pylypchuk and Jeff Harrison and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Billy Wu

18 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Billy Wu New Zealand 10 228 87 77 61 59 18 431
Roma Puronaitė Lithuania 12 190 0.8× 82 0.9× 39 0.5× 92 1.5× 33 0.6× 52 415
Huynh Van Minh Vietnam 13 317 1.4× 74 0.9× 197 2.6× 122 2.0× 17 0.3× 43 632
Narendra Singh Canada 11 323 1.4× 104 1.2× 99 1.3× 51 0.8× 39 0.7× 35 563
Ana Cristina Perez Moreno United States 14 713 3.1× 141 1.6× 86 1.1× 110 1.8× 41 0.7× 41 972
T C Chalmers United States 11 91 0.4× 165 1.9× 39 0.5× 65 1.1× 49 0.8× 19 643
Graham Cole United Kingdom 2 553 2.4× 67 0.8× 66 0.9× 82 1.3× 55 0.9× 2 691
Shaleah Levant United States 6 183 0.8× 48 0.6× 15 0.2× 143 2.3× 28 0.5× 7 520
Valeria Vietto Argentina 12 37 0.2× 122 1.4× 57 0.7× 52 0.9× 66 1.1× 26 604
Gema Vega Spain 12 256 1.1× 78 0.9× 21 0.3× 88 1.4× 28 0.5× 25 486
Eliana Vieira Santucci Brazil 8 161 0.7× 151 1.7× 57 0.7× 23 0.4× 69 1.2× 16 390

Countries citing papers authored by Billy Wu

Since Specialization
Citations

This map shows the geographic impact of Billy Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Wu more than expected).

Fields of papers citing papers by Billy Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Billy Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Wu. The network helps show where Billy Wu may publish in the future.

Co-authorship network of co-authors of Billy Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Billy Wu. A scholar is included among the top collaborators of Billy Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Billy Wu. Billy Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wu, Billy, Suneela Mehta, Matire Harwood, et al.. (2022). Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand. SHILAP Revista de lepidopterología. 1(1). e000081–e000081. 11 indexed citations
2.
Pylypchuk, Romana, Sue Wells, Andrew Kerr, et al.. (2021). Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study. The Lancet. 397(10291). 2264–2274. 33 indexed citations
3.
Kerr, Andrew, et al.. (2021). Nationwide dispensing of cardioprotective medications during the first year following acute coronary syndrome (ANZACS-QI 56).. PubMed. 134(1531). 36–54. 1 indexed citations
4.
Parkin, Lianne, Sheila Williams, Katrina Sharples, et al.. (2021). Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population‐based nested case–control study. Journal of Internal Medicine. 290(5). 1028–1038. 7 indexed citations
5.
Grey, Corina, Rod Jackson, Sue Wells, et al.. (2020). Both incidence and prevalence of ischaemic heart disease are declining in parallel: a national data-linkage study in New Zealand (ANZACS-QI 52). European Journal of Preventive Cardiology. 29(2). 321–327. 3 indexed citations
6.
Pylypchuk, Romana, Sue Wells, Andrew Kerr, et al.. (2020). Cardiovascular Risk Prediction in Type 2 Diabetes Before and After Widespread Screening: A Derivation and Validation Study. SSRN Electronic Journal. 4 indexed citations
7.
Mehta, Suneela, Rod Jackson, Daniel Exeter, et al.. (2019). Data Resource: Vascular Risk in Adult New Zealanders (VARIANZ) datasets. International Journal for Population Data Science. 4(1). 1107–1107. 8 indexed citations
8.
Poppe, Katrina, Robert N. Doughty, Susan Wells, et al.. (2019). Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome. Heart. 106(7). 506–511. 6 indexed citations
9.
Earle, Nikki, Andrew Kerr, Malcolm E. Legget, et al.. (2019). Acute coronary syndrome registry enrolment status: differences in patient characteristics and outcomes and implications for registry data use (ANZACS-QI 36). European Heart Journal - Quality of Care and Clinical Outcomes. 7(6). 542–547. 5 indexed citations
10.
Selak, Vanessa, Rod Jackson, Katrina Poppe, et al.. (2019). Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease. Annals of Internal Medicine. 170(6). 357–368. 27 indexed citations
11.
Selak, Vanessa, Rod Jackson, Katrina Poppe, et al.. (2019). Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention. Annals of Internal Medicine. 171(8). 529–539. 16 indexed citations
12.
Pylypchuk, Romana, Sue Wells, Andrew Kerr, et al.. (2018). Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study. The Lancet. 391(10133). 1897–1907. 190 indexed citations
13.
Selak, Vanessa, Andrew Kerr, Katrina Poppe, et al.. (2018). Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy. JAMA. 319(24). 2507–2507. 35 indexed citations
14.
Wells, Sue, Katrina Poppe, Vanessa Selak, et al.. (2018). Is general practice identification of prior cardiovascular disease at the time of CVD risk assessment accurate and does it matter?. PubMed. 131(1475). 10–20. 5 indexed citations
15.
Grey, Corina, Rod Jackson, Susan Wells, et al.. (2018). Trends in ischaemic heart disease: patterns of hospitalisation and mortality rates differ by ethnicity (ANZACS-QI 21).. PubMed. 131(1478). 21–31. 25 indexed citations
16.
Grey, Corina, Rod Jackson, Susan Wells, et al.. (2017). First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005–2015. Heart. 104(1). 51–57. 19 indexed citations
17.
Exeter, Daniel, Billy Wu, Arier Lee, & Grant D. Searchfield. (2015). The projected burden of hearing loss in New Zealand (2011-2061) and the implications for the hearing health workforce.. PubMed. 128(1419). 12–21. 10 indexed citations
18.
Wu, Billy, Grant D. Searchfield, Daniel Exeter, & Arier Lee. (2015). Tinnitus prevalence in New Zealand.. PubMed. 128(1423). 24–34. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026